☰

Defne Yarar, Ph.D. - Publications

Affiliations: 
2002 University of California, Berkeley, Berkeley, CA, United States 
Area:
Actin polymerization
Tree Info Grants Similar researchers PubMed Report error

18/30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Yarar D, Lahdenranta J, Kubasek W, Nielsen UB, MacBeath G. Heregulin-ErbB3-Driven Tumor Growth Persists in PI3 Kinase Mutant Cancer Cells. Molecular Cancer Therapeutics. PMID 26116360 DOI: 10.1158/1535-7163.Mct-15-0075  0.334
2014 Thiru P, Kern DM, McKinley KL, Monda JK, Rago F, Su KC, Tsinman T, Yarar D, Bell GW, Cheeseman IM. Kinetochore genes are coordinately up-regulated in human tumors as part of a FoxM1-related cell division program. Molecular Biology of the Cell. 25: 1983-94. PMID 24829384 DOI: 10.1091/Mbc.E14-03-0837  0.323
2010 Batchelder EM, Yarar D. Differential requirements for clathrin-dependent endocytosis at sites of cell-substrate adhesion. Molecular Biology of the Cell. 21: 3070-9. PMID 20631253 DOI: 10.1091/Mbc.E09-12-1044  0.454
2010 Sisan DR, Yarar D, Waterman CM, Urbach JS. Event ordering in live-cell imaging determined from temporal cross-correlation asymmetry. Biophysical Journal. 98: 2432-41. PMID 20513386 DOI: 10.1016/J.Bpj.2010.02.041  0.365
2010 Mettlen M, Loerke D, Yarar D, Danuser G, Schmid SL. Cargo- and adaptor-specific mechanisms regulate clathrin-mediated endocytosis. The Journal of Cell Biology. 188: 919-33. PMID 20231386 DOI: 10.1083/Jcb.200908078  0.346
2009 Loerke D, Mettlen M, Yarar D, Jaqaman K, Jaqaman H, Danuser G, Schmid SL. Cargo and dynamin regulate clathrin-coated pit maturation. Plos Biology. 7: e57. PMID 19296720 DOI: 10.1371/Journal.Pbio.1000057  0.39
2008 Yarar D, Surka MC, Leonard MC, Schmid SL. SNX9 activities are regulated by multiple phosphoinositides through both PX and BAR domains. Traffic (Copenhagen, Denmark). 9: 133-46. PMID 17988218 DOI: 10.1111/J.1600-0854.2007.00675.X  0.33
2007 Alto NM, Weflen AW, Rardin MJ, Yarar D, Lazar CS, Tonikian R, Koller A, Taylor SS, Boone C, Sidhu SS, Schmid SL, Hecht GA, Dixon JE. The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways. The Journal of Cell Biology. 178: 1265-78. PMID 17893247 DOI: 10.1083/Jcb.200705021  0.425
2007 Yarar D, Waterman-Storer CM, Schmid SL. SNX9 couples actin assembly to phosphoinositide signals and is required for membrane remodeling during endocytosis. Developmental Cell. 13: 43-56. PMID 17609109 DOI: 10.1016/J.Devcel.2007.04.014  0.467
2005 Soulet F, Yarar D, Leonard M, Schmid SL. SNX9 regulates dynamin assembly and is required for efficient clathrin-mediated endocytosis. Molecular Biology of the Cell. 16: 2058-67. PMID 15703209 DOI: 10.1091/Mbc.E04-11-1016  0.491
2005 Yarar D, Waterman-Storer CM, Schmid SL. A dynamic actin cytoskeleton functions at multiple stages of clathrin-mediated endocytosis. Molecular Biology of the Cell. 16: 964-75. PMID 15601897 DOI: 10.1091/Mbc.E04-09-0774  0.499
2004 Adams MC, Matov A, Yarar D, Gupton SL, Danuser G, Waterman-Storer CM. Signal analysis of total internal reflection fluorescent speckle microscopy (TIR-FSM) and wide-field epi-fluorescence FSM of the actin cytoskeleton and focal adhesions in living cells. Journal of Microscopy. 216: 138-52. PMID 15516225 DOI: 10.1111/J.0022-2720.2004.01408.X  0.38
2004 Song BD, Yarar D, Schmid SL. An assembly-incompetent mutant establishes a requirement for dynamin self-assembly in clathrin-mediated endocytosis in vivo. Molecular Biology of the Cell. 15: 2243-52. PMID 15004222 DOI: 10.1091/Mbc.E04-01-0015  0.358
2003 Yarar D. Cortical patches on the move. Cell. 115: 373-5. PMID 14622592 DOI: 10.1016/S0092-8674(03)00890-0  0.383
2003 Vignjevic D, Yarar D, Welch MD, Peloquin J, Svitkina T, Borisy GG. Formation of filopodia-like bundles in vitro from a dendritic network. The Journal of Cell Biology. 160: 951-62. PMID 12642617 DOI: 10.1083/Jcb.200208059  0.581
2002 Yarar D, D'Alessio JA, Jeng RL, Welch MD. Motility determinants in WASP family proteins. Molecular Biology of the Cell. 13: 4045-59. PMID 12429845 DOI: 10.1091/Mbc.E02-05-0294  0.575
1999 Yarar D, To W, Abo A, Welch MD. The Wiskott-Aldrich syndrome protein directs actin-based motility by stimulating actin nucleation with the Arp2/3 complex. Current Biology : Cb. 9: 555-8. PMID 10339430 DOI: 10.1016/S0960-9822(99)80243-7  0.606
1997 Winey M, Yarar D, Giddings TH, Mastronarde DN. Nuclear pore complex number and distribution throughout the Saccharomyces cerevisiae cell cycle by three-dimensional reconstruction from electron micrographs of nuclear envelopes. Molecular Biology of the Cell. 8: 2119-32. PMID 9362057 DOI: 10.1091/Mbc.8.11.2119  0.321
Low-probability matches (unlikely to be authored by this person)
2012 Onsum M, Yarar D, Paragas V, Zhang B, Nguyen S, Schoeberl B, McDonagh C, MacBeath G, Nielsen U. Abstract 4945: Targeting ErbB3-addicted cancers across the HER2 spectrum Cancer Research. 72: 4945-4945. DOI: 10.1158/1538-7445.Am2012-4945  0.3
2019 Hlavaty KA, Booty MG, Loughhead S, Blagovic K, Vicente-Suarez A, Yarar D, Bernstein H, Sharei A. Abstract 3187: Engineering a new generation of cell therapies for solid tumor oncology using the SQZ platform Cancer Research. 79: 3187-3187. DOI: 10.1158/1538-7445.Am2019-3187  0.281
2011 Kirouac DC, Lahdenranta J, Overland R, Oyama S, Yarar D, Onsum M, McDonagh C, Nielson U. Abstract C118: Optimization of MM-111 and lapatinib dosing regimens using mathematical modeling and quantitative biology. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C118  0.266
2013 Kirouac DC, Du JY, Lahdenranta J, Overland R, Yarar D, Paragas V, Pace E, McDonagh CF, Nielsen UB, Onsum MD. Computational modeling of ERBB2-amplified breast cancer identifies combined ErbB2/3 blockade as superior to the combination of MEK and AKT inhibitors. Science Signaling. 6: ra68. PMID 23943608 DOI: 10.1126/Scisignal.2004008  0.259
2017 Schoeberl B, Kudla A, Masson K, Kalra A, Curley M, Finn G, Pace E, Harms B, Kim J, Kearns J, Fulgham A, Burenkova O, Grantcharova V, Yarar D, Paragas V, et al. Systems biology driving drug development: from design to the clinical testing of the anti-ErbB3 antibody seribantumab (MM-121). Npj Systems Biology and Applications. 3: 16034. PMID 28725482 DOI: 10.1038/npjsba.2016.34  0.181
2022 Blagovic K, Smith CK, Ramakrishnan A, Moore L, Soto DR, Thompson Z, Stockmann AP, Kruszelnicki S, Thakkar A, Murray J, Torres S, Wondimagegnhu B, Yi R, Dadgar M, Paracha AM, ... ... Yarar D, et al. Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice. Frontiers in Immunology. 13: 1015585. PMID 36263022 DOI: 10.3389/fimmu.2022.1015585  0.158
2015 Kirouac DC, Lahdenranta J, Du J, Yarar D, Onsum MD, Nielsen UB, McDonagh CF. Model-Based Design of a Decision Tree for Treating HER2+ Cancers Based on Genetic and Protein Biomarkers. Cpt: Pharmacometrics & Systems Pharmacology. 4: e00019. PMID 26225238 DOI: 10.1002/psp4.19  0.154
2022 Booty MG, Hlavaty KA, Stockmann A, Ozay EI, Smith C, Tian L, How E, Subramanya D, Venkitaraman A, Yee C, Pryor O, Volk K, Blagovic K, Vicente-Suarez I, Yarar D, et al. Microfluidic Squeezing Enables MHC Class I Antigen Presentation by Diverse Immune Cells to Elicit CD8 T Cell Responses with Antitumor Activity. Journal of Immunology (Baltimore, Md. : 1950). PMID 35091434 DOI: 10.4049/jimmunol.2100656  0.136
2018 Loughhead S, Booty M, Hlavaty K, Vicente-Suarez A, Blagovic K, Myint M, Stokes B, Yarar D, Bernstein H, Sharei A. SQZing cells to rapidly generate antigen presenting cells (APC) for solid tumor immune therapies with efficient, scalable manufacturing Annals of Oncology. 29: x13. DOI: 10.1093/annonc/mdy485.007  0.132
2011 Banwait R, O'Regan K, Campigotto F, Harris B, Yarar D, Bagshaw M, Leleu X, Leduc R, Ramaiya N, Weller E, Ghobrial IM. The role of 18F-FDG PET/CT imaging in Waldenstrom macroglobulinemia. American Journal of Hematology. 86: 567-72. PMID 21681781 DOI: 10.1002/ajh.22044  0.057
2012 Shashaty MG, Meyer NJ, Localio AR, Gallop R, Bellamy SL, Holena DN, Lanken PN, Kaplan S, Yarar D, Kawut SM, Feldman HI, Christie JD. African American race, obesity, and blood product transfusion are risk factors for acute kidney injury in critically ill trauma patients. Journal of Critical Care. 27: 496-504. PMID 22591570 DOI: 10.1016/J.Jcrc.2012.02.002  0.042
1999 Yarar D, Cheung AK, Sakiewicz P, Lindsay RM, Paganini EP, Steuer RR, Leypoldt JK. Ultrafiltration method for measuring vascular access flow rates during hemodialysis. Kidney International. 56: 1129-35. PMID 10469383 DOI: 10.1046/j.1523-1755.1999.00631.x  0.018
Hide low-probability matches.